RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 51 filers reported holding RENEO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,480,000 | – | 1,750,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,534,220 | $16,624,483 | 18.44% |
| Aisling Capital Management LP | 886,075 | $5,812,652 | 2.85% |
| Octagon Capital Advisors LP | 2,368,587 | $15,537,931 | 2.16% |
| NEA Management Company, LLC | 4,785,494 | $28,253,557 | 2.16% |
| Novo Holdings A/S | 3,330,377 | $21,847,273 | 1.69% |
| GREAT POINT PARTNERS LLC | 1,083,317 | $7,106,560 | 1.39% |
| Carlyle Group Inc. | 2,698,957 | $17,678,168 | 0.63% |
| Eventide Asset Management | 1,750,000 | $11,480,000 | 0.19% |
| Rock Springs Capital Management LP | 1,143,185 | $7,499,294 | 0.18% |
| Ikarian Capital, LLC | 155,819 | $1,022,173 | 0.16% |